Anson Funds Management’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,770
Closed -$282K 57
2016
Q4
$282K Buy
+6,770
New +$282K 0.09% 51